News and Updates

A controversial embryonic stem cell company in Massachusetts fights to survive as it struggles with increasing debt.

In a visually dramatic graphical representation, Drs. Rudolf Jaenisch and Christopher Lengner describe and contrast the properties of embryonic stem cells and pluripotent cells derived from non-embryonic sources.

NeoStem CEO, Dr. Robin Smith, will speak about “medical tourism” at the 2008 World Stem Cell Summit.

Scientists have transformed one type of adult cell into another type, without the use of stem cells.

Researchers at Stanford University have once again confirmed problems with immune rejection that are inherent in embryonic stem cells.

Two major biotech companies in the stem cell industry sign yet another licensing agreement.